Pharsight

ARAGON PHARMACEUTICALS INC PATENTS FACING OPPOSITIONS

Top patents of ARAGON PHARMACEUTICALS INC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2945628B1 15 Apr, 2020 Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer Jan, 2034 4
EP3305285B1 02 Sep, 2020 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer Sep, 2033 3
EP3226842B1 25 Nov, 2020 Anticancer compositions Dec, 2035 2
EP3226843B1 26 May, 2021 Anticancer compositions Dec, 2035 1